Xcout Intel
Tortugas Neuroscience competitors & alternatives
The 12 closest competitors and alternatives to Tortugas Neuroscience among drug discovery companies — ranked by similarity to what Tortugas Neuroscience actually does, not by market-cap band.
Subscribe to see Tortugas Neuroscience’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Tortugas Neuroscience
Tortugas Neuroscience is a drug discovery and biopharmaceutical company headquartered in Framingham, Massachusetts. The company focuses on advancing innovative neuroscience therapeutics.
Tortugas Neuroscience at a glance
Tortugas Neuroscience is a drug discovery company headquartered in United States. Its most recent funding round, Seed and Series A, raised $106M in April 2026. Xcout tracks 1 named person at Tortugas Neuroscience, including Jeff Jonas (CEO).
Tortugas Neuroscience leadership
- Jeff JonasCEO
Tortugas Neuroscience funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed and Series A | $106M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Tortugas Neuroscience competitors
Ranked by semantic similarity — how close each company is to Tortugas Neuroscience by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Neurasic Therapeutics is a Montreal-based drug discovery company founded in 2020 and based on research from McGill University's Montreal Neurological Institute. The company develops therapeutic solutions and medicinal drugs aimed at treating neurological disorders, with a primary focus on advancing opiate-sparing, pain-relieving treatments such as substituted thiophene for neuropathic and inflammatory pain.
Similar drug discovery company
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
Similar drug discovery company
FundaMental Pharma is a biopharmaceutical spin-off established from Heidelberg University and headquartered in Heidelberg, Germany. Its research focuses on developing novel therapeutic approaches and treatments for neurological disorders.
Similar drug discovery company
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Similar drug discovery company
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Similar drug discovery company
Goldenrod Therapeutics, Inc. is a biotechnology innovator based in Houston, Texas, developing treatments for brain inflammation and PDE4B inhibitors for neurological conditions and substance use disorder.
Similar drug discovery company
Retrotope, Inc. is a drug development company headquartered in Los Altos, California, focused on creating therapeutics for degenerative diseases.
Medtech
IAMA Therapeutics is a clinical-stage pharmaceutical and biotechnology company founded in 2021 and headquartered in Genoa, Italy. The firm is dedicated to researching and developing innovative, disease-modifying medicines to treat brain disorders.
Biopharma
Engrail Therapeutics, Inc. is a clinical-stage neurosciences and pharmaceutical company established in 2019 and headquartered in San Diego, California. The firm focuses on developing novel treatments such as its planned ENX-104 clinical program.
Biopharmaceuticals
AgeneBio, Inc. is a development-stage CNS biopharmaceutical company located in Baltimore, Maryland, focused on discovering and developing innovative therapeutics to preserve and restore brain function.
Biopharmaceuticals
1ST Biotherapeutics is a South Korean biopharmaceutical company focused on discovering and developing treatments for neurodegenerative and other central nervous system diseases. Its work is aimed at patients with disorders such as Alzheimer’s disease and related conditions.
Biopharmaceuticals
Biohaven is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments across key therapeutic areas. Headquartered with operations in New Haven, Connecticut, the company advances innovative neuroscience and specialty therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Tortugas Neuroscience and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Tortugas Neuroscienceand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →